Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Importance Patients with cancer undergoing treatment are at high risk of COVID-19 following
SARS-CoV-2 infection; however, their ability to produce an adequate antibody response to …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is still in an epidemic
situation, which poses a serious threat to the safety of people and property. Rapid diagnosis …

AO, JZ, LC, NC, NK, AS, and FL participated in research design. AO, AS, FA, CC, JI, ML-. V.,
NC, and NK participated in data analysis. AO, AS, CL, LC, ML-. V., NC, and NK participated …

Poor responses to mRNA COVID-19 vaccine have been reported after 2 vaccine injections
in kidney transplant recipients (KTRs) treated with belatacept. We analyzed the humoral …

Recently published studies have found an impaired immune response after SARS‐CoV‐2
vaccination in solid organ recipients. However, most of these studies have not assessed …

Summary Background Introduction of the Omicron variant caused a steep rise in SARS-CoV-
2 infections despite high vaccination coverage in the Danish population. We used blood …

There is still a need for safe, efficient, and low-cost coronavirus disease 2019 (COVID-19)
vaccines that can stop transmission of severe acute respiratory syndrome coronavirus 2 …

Anti-viral immunity continuously declines over time after SARS-CoV-2 infection. Here, we
characterize the dynamics of anti-viral immunity during long-term follow-up and after …

Objective With a vaccine effectiveness of 95% for preventing coronavirus disease 2019
(COVID‐19), Pfizer‐BioNTech BNT162b2 (BNT162b2) was the first vaccine against severe …